CRYL1 and hepatocellular carcinoma: Considering the potential involvement of these two genes in HCC, the fusion transcript we identified here might be responsible for the tumorigenesis and serve as potential targets for further therapeutic strategy by the overexpression of IFT88 to overcome the function inhibition due to gene fusion CRYL1-IFT88.